Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis

American Journal of Gastroenterology

Volumn 102, Issue 9, 2007, Pages 1939-1946

  Komura, Takuya ^a   Mizukoshi, Eishiro ^a   Kita, Yuki ^a   Sakurai, Masaru ^a   Takata, Yoshiko ^a   Arai, Kuniaki ^a   Yamashita, Tatsuya ^a   Ohta, Tetsuo ^a   Shimizu, Koichi ^a   Nakamoto, Yasunari ^a   Honda, Masao ^a   Takamura, Toshinari ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS C; HUMAN; INSULIN TREATMENT; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE; UNIVARIATE ANALYSIS; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; FEMALE; HEPATECTOMY; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 34548131591     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01354.x     Document Type: Article

References (46)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999 19 : 271 85.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999 340 : 745 50.
3. Heathcote EJ. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 2004 127 : S294 302.
4. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996 83 : 1219 22.
5. Poon RT, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 1999 229 : 216 22.
6. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995 108 : 768 75.
7. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993 71 : 19 25.
8. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan. Cancer 1994 74 : 2772 80.
9. Koike Y, Shiratori Y, Sato S, et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology 2000 32 : 1216 23.
10. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 126 : 460 8.
11. Davila JA, Morgan RO, Shaib Y, et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 2005 54 : 533 39.
12. Ikeda Y, Shimada M, Hasegawa H, et al. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998 27 : 1567 71.
13. Poon RT, Fan ST, Wong J. Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol 2002 97 : 1480 8.
14. Toyoda H, Kumada T, Nakano S, et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 2001 91 : 957 63.
15. Araki T, Itai Y, Furui S, et al. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 1980 135 : 1037 43.
16. Japan. LCSGo. Classification of primary liver cancer, English 2nd Ed. Tokyo : Kanehara & Co., Ltd., 1997.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 : 1183 97.
18. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994 19 : 1513 20.
19. Katsuki A, Sumida Y, Gabazza E, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001 24 : 362 5.
20. Huo TI, Wu JC, Lui WY, et al. Diabetes mellitus is a recurrence- independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol 2003 15 : 1203 8.
21. Szabo E, Paska C, Kaposi Novak P, et al. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 2004 10 : 5 11.
22. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms. Gastroenterology 2004 127 : S56 61.
23. Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 2004 127 : S62 71.
24. Honda M, Kaneko S, Kawai H, et al. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001 120 : 955 66.
25. Edamoto Y, Hara A, Biernat W, et al. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 2003 106 : 334 41.
26. Iizuka N, Oka M, Yamada-Okabe H, et al. Differential gene expression in distinct virologic types of hepatocellular carcinoma: Association with liver cirrhosis. Oncogene 2003 22 : 3007 14.
27. Laurent-Puig P, Legoix P, Bluteau O, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001 120 : 1763 73.
28. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002 31 : 339 46.
29. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
30. Sung VM, Shimodaira S, Doughty AL, et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: The apoptotic effects of virus infection. J Virol 2003 77 : 2134 46.
31. Guo JT, Zhou H, Liu C, et al. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol 2000 74 : 1495 505.
32. Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999 4 : 199 207.
33. Shiratori Y, Shiina S, Teratani T, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003 138 : 299 306.
34. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin Liver Dis 2001 21 : 57 69.
35. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001 21 : 27 41.
36. Takamura T, Sakurai M, Ota T, et al. Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. Diabetologia 2004 47 : 638 47.
37. Fong DG, Nehra V, Lindor KD, et al. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000 32 : 3 10.
38. Brechot C, Pourcel C, Louise A, et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980 286 : 533 5.
39. Kim CM, Koike K, Saito I, et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991 351 : 317 20.
40. Bressac B, Galvin KM, Liang TJ, et al. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990 87 : 1973 7.
41. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003 35 : 694 704.
42. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996 5 : 1013 5.
43. Swerdlow AJ, Laing SP, Qiao Z, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: A UK cohort study. Br J Cancer 2005 92 : 2070 5.
44. Schiel R, Muller UA, Braun A, et al. Risk of malignancies in patients with insulin-treated diabetes mellitus - results of a population-based trial with 10-year follow-up (JEVIN). Eur J Med Res 2005 10 : 339 44.
45. Chuang TY, Lewis DA, Spandau DF. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: A pilot study. Br J Dermatol 2005 153 : 552 7.
46. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004 127 : 1044 50.